Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study

Abstract

Combination antimicrobial therapy represents common practice in the treatment of febrile neutropenia aiming to broaden the antimicrobial spectrum against Gram-negative pathogens. We did a prospective, non-randomized, comparative study to evaluate ceftazidime plus either levofloxacin or once-daily amikacin as empirical regimens for febrile neutropenia in… (More)
DOI: 10.1007/s10096-011-1454-0

Topics

5 Figures and Tables

Cite this paper

@article{Samonis2011EmpiricalTW, title={Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study}, author={George Samonis and Eirini Koutsounaki and Drosos E. Karageorgopoulos and Pantelis K. Mitsikostas and C Kalpadaki and Vasiliki Bozionelou and Iliada Bompolaki and Joseph Sgouros and V. Taktikou and Matthew E. Falagas}, journal={European Journal of Clinical Microbiology & Infectious Diseases}, year={2011}, volume={31}, pages={1389-1398} }